# Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence

> **NCT02566928** · PHASE4 · UNKNOWN · sponsor: **Clinical Directors Network** · enrollment: 278 (estimated)

## Conditions studied

- Methicillin-Resistant Staphylococcus Aureus
- Recurrence
- Staphylococcal Skin Infections
- Antibiotic Resistance

## Interventions

- **DRUG:** 2% mupirocin ointment
- **OTHER:** Chlorhexidine wash
- **BEHAVIORAL:** Hygiene protocol

## Key facts

- **NCT ID:** NCT02566928
- **Lead sponsor:** Clinical Directors Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2018-11
- **Final completion:** 2018-12-31
- **Target enrollment:** 278 (ESTIMATED)
- **Last updated:** 2017-07-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02566928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02566928, "Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02566928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*